On the pharmacokinetics of phenacetin in man
- PMID: 1233222
- DOI: 10.1007/BF00567125
On the pharmacokinetics of phenacetin in man
Abstract
The pharmacokinetic characteristics of the analgesic phenacetin have been determined in six healthy adults. After rapid i.v. injection of 250 mg phenacetin, the log plasma concentrations versus time curves were evaluated according to the rules of a two-compartment open model. The elimination half-life (t1/2)beta varied from 37 to 74 minutes. The volume of distribution (Vd)beta ranged from 1.0 to 2.1 1 per kg body weight. The total clearance of the drug was high and approximated the average value of hepatic blood flow in normal adults. In agreement with this finding, the bioavailability of a small oral dose of phenacetin (0.25 g) was almost nil, as the bulk of the drug was cleared during its first pass through the liver. With large oral doses (1.0 g) the first-pass effect decreased and availability increased. The results are discussed and related to current general views of the liver-first-pass phenomenon.
Similar articles
-
Temporal variations in acetaminophen and phenacetin half-life in man.Clin Pharmacol Ther. 1975 Oct;18(4):413-24. doi: 10.1002/cpt1975184413. Clin Pharmacol Ther. 1975. PMID: 1100307 Clinical Trial.
-
In vivo O-de-ethylation of phenacetin in 3-methylcholanthrene-pretreated rats: gut wall and liver first-pass metabolism.J Pharmacol Exp Ther. 1983 Apr;225(1):153-7. J Pharmacol Exp Ther. 1983. PMID: 6834267
-
Turpentine oil induced inflammation decreases absorption and increases distribution of phenacetin without altering its elimination process in rats.Eur J Drug Metab Pharmacokinet. 2015 Mar;40(1):23-8. doi: 10.1007/s13318-013-0172-7. Epub 2013 Dec 20. Eur J Drug Metab Pharmacokinet. 2015. PMID: 24356809
-
High-dose morphine and methadone in cancer patients. Clinical pharmacokinetic considerations of oral treatment.Clin Pharmacokinet. 1986 Mar-Apr;11(2):87-106. doi: 10.2165/00003088-198611020-00001. Clin Pharmacokinet. 1986. PMID: 3514045 Review.
-
Clinical pharmacokinetics of beta-adrenoreceptor blocking drugs.Clin Pharmacokinet. 1976;1(4):233-63. doi: 10.2165/00003088-197601040-00001. Clin Pharmacokinet. 1976. PMID: 13958 Review.
Cited by
-
Dose dependent pharmacokinetics of midazolam.Eur J Clin Pharmacol. 1985;29(1):91-5. doi: 10.1007/BF00547375. Eur J Clin Pharmacol. 1985. PMID: 2932334
-
Pharmacokinetics of lorcainide in man: a new antiarrhythmic agent.Clin Pharmacokinet. 1978 Sep-Oct;3(5):407-18. doi: 10.2165/00003088-197803050-00006. Clin Pharmacokinet. 1978. PMID: 699462
-
Dose dependence of the 14C-aminopyrine breath test. Intrasubject comparison of tracer and pharmacological doses.Eur J Clin Pharmacol. 1977 Nov 14;12(3):229-33. doi: 10.1007/BF00609866. Eur J Clin Pharmacol. 1977. PMID: 590310 Clinical Trial.
-
First-pass elimination. Basic concepts and clinical consequences.Clin Pharmacokinet. 1984 Jan-Feb;9(1):1-25. doi: 10.2165/00003088-198409010-00001. Clin Pharmacokinet. 1984. PMID: 6362950 Review.
-
A kinetic evaluation of 14CO2 in expired air after 14C-methacetin administration in rats, used for the in vivo study of the metabolism of drugs.Eur J Drug Metab Pharmacokinet. 1984 Apr-Jun;9(2):161-8. doi: 10.1007/BF03189620. Eur J Drug Metab Pharmacokinet. 1984. PMID: 6430705
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources